课题基金 / 基金详情

MOLECULAR REGULATION OF INTERLEUKIN 12 GENE EXPRESSION

MOLECULAR REGULATION OF INTERLEUKIN 12 GENE EXPRESSION
白介素 12 基因表达的分子调控
批准号:
6362686
负责人:
XIAOJING MA
金额:
$15.77万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-10 至 2004-02-29

项目摘要

项目成果

XIAOJING MA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Interleukin-12 is a pivotal cytokine representing the link between the cellular and humoral branches of an effective host immune defense apparatus. It is a key factor in the induction of T-cell dependent and independent activation of macrophages, generation of T helped type 1 and cytotoxic T cells, resistance to bacterial and parasitic infections, and elimination of tumors. IL-12 is a heterodimer consisted to two subunits, p40 and p35 that are encoded on different human chromosomes. The expression of these two genes are highly coordinated to form the biologically active IL-12 during an effective immune response. However, under some pathological conditions IL-12 is dysregulated, resulting either in a lack of resistance to microbial infection and uncontrolled tumor growth, or in destructive inflammation. We hypothesize that a transient or irreversible dysregulation of IL-12 production reflects a pathogen/tumor cell-induced disruption in the highly coordinated expression of p40 and p35 genes. This proposal is aimed at: (1) identifying and characterizing the transcription factors which activate factors which activate IL-12 p40 gene expression in response to pathogenic stimulation; (2) investigating the molecular mechanisms of IL-12 p40 gene expression in response to pathogenic stimulation; (2) investigating the molecular mechanism of IL-12 p40 gene expression in T, B and monocytic cells; (3) analyzing the molecular basis of inhibition of IL-12 gene expression by immunosuppressive agents. The understanding of the molecular mechanisms governing the expression of IL-12 p40 and p35 genes in the context of interactions between pathogens and the immune system will benefit significantly our efforts in designing therapeutic strategies to treat infectious and malignant diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UBR5's mechanisms of action in tumorigenesis and immunoregulation
Role of two novel genes in IL-23 production and Th17-mediated pathogenesis in SLE
Role of two novel genes in IL-23 production and Th17-mediated pathogenesis in SLE
Mechanism of Progranulin-mediated control of septic inflammation via IL-10
海外基金